NASDAQ:LQDA Liquidia (LQDA) Stock Price, News & Analysis $14.10 -0.88 (-5.87%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Liquidia Stock (NASDAQ:LQDA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Liquidia alerts:Sign Up Key Stats Today's Range$13.86▼$15.0650-Day Range$11.99▼$19.3052-Week Range$8.26▼$19.41Volume2.72 million shsAverage Volume1.18 million shsMarket Capitalization$1.20 billionP/E RatioN/ADividend YieldN/APrice Target$26.67Consensus RatingBuy Company OverviewLiquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Read More… Liquidia Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreLQDA MarketRank™: Liquidia scored higher than 75% of companies evaluated by MarketBeat, and ranked 249th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingLiquidia has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageLiquidia has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Liquidia's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Liquidia are expected to grow in the coming year, from ($1.51) to ($1.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -8.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -8.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia has a P/B Ratio of 19.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Liquidia's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted22.82% of the float of Liquidia has been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 10, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently decreased by 0.30%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted22.82% of the float of Liquidia has been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 10, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently decreased by 0.30%, indicating that investor sentiment is improving. News and Social Media3.3 / 5News Sentiment0.85 News SentimentLiquidia has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Liquidia this week, compared to 6 articles on an average week.Search Interest12 people have searched for LQDA on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows4 people have added Liquidia to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $450,233.00 in company stock.Percentage Held by Insiders26.50% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.54% of the stock of Liquidia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Liquidia's insider trading history. Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address LQDA Stock News HeadlinesInsmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, LiquidiaJune 10 at 10:53 AM | msn.comLiquidia Begins Commercial Rollout Of YUTREPIA For PAH And PH-ILD After FDA ApprovalJune 4, 2025 | nasdaq.comThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.June 11, 2025 | Priority Gold (Ad)Stocks To Watch: Liquidia Sees Relative Strength Rating Jump To 93June 4, 2025 | msn.comBTIG Raises Liquidia Price Target Following YUTREPIA ApprovalJune 4, 2025 | msn.comLiquidia Technologies (LQDA) Receives a Buy from LifeSci CapitalJune 3, 2025 | theglobeandmail.comLiquidia Shares Rise on Scheduled Commercial Shipment of YutrepiaJune 2, 2025 | marketwatch.comLiquidia stock rises following YUTREPIA shipment newsJune 2, 2025 | in.investing.comSee More Headlines LQDA Stock Analysis - Frequently Asked Questions How have LQDA shares performed this year? Liquidia's stock was trading at $11.76 at the beginning of 2025. Since then, LQDA stock has increased by 19.9% and is now trading at $14.0960. View the best growth stocks for 2025 here. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) issued its quarterly earnings data on Thursday, May, 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by $0.03. The company earned $3.12 million during the quarter, compared to analyst estimates of $3.23 million. Liquidia had a negative net margin of 765.38% and a negative trailing twelve-month return on equity of 163.21%. Read the conference call transcript. When did Liquidia IPO? Liquidia (LQDA) raised $50 million in an initial public offering on Thursday, July 26th 2018. The company issued 4,500,000 shares at $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. Who are Liquidia's major shareholders? Top institutional shareholders of Liquidia include Vanguard Group Inc. (4.06%), Vestal Point Capital LP (1.44%), Goldman Sachs Group Inc. (1.01%) and Boothbay Fund Management LLC (0.78%). Insiders that own company stock include Caligan Partners Lp, Roger Jeffs, Russell Schundler, Michael Kaseta, Rajeev Saggar, Robert A Lippe, Jason Adair and Scott Moomaw. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia investors own include JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Ford Motor (F), Predictive Oncology (POAI), Tesla (TSLA), Advanced Micro Devices (AMD) and Abbott Laboratories (ABT). Company Calendar Last Earnings5/08/2025Today6/11/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryMedical Equipment Current SymbolNASDAQ:LQDA CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$26.67 High Stock Price Target$37.00 Low Stock Price Target$13.00 Potential Upside/Downside+78.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$78.50 million Net Margins-765.38% Pretax Margin-765.38% Return on Equity-163.21% Return on Assets-67.14% Debt Debt-to-Equity RatioN/A Current Ratio6.33 Quick Ratio6.33 Sales & Book Value Annual Sales$14.14 million Price / Sales90.54 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book20.52Miscellaneous Outstanding Shares85,485,000Free Float59,161,000Market Cap$1.28 billion OptionableOptionable Beta0.04 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:LQDA) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LQDA Stock Free LQDA Stock Alerts